The author argues that nutrition should be evaluated by how food affects metabolism, mitochondrial function, inflammation, nutrient density, toxins and long-term physiologic resilience. One of the central themes is that humans evolved as metabolically flexible omnivores (consume plants, animals, algae & fungi), capable of shifting between glucose, fat and ketone metabolism depending on environmental conditions and food availability.

Instead of claiming one perfect diet for everyone, the paper discusses both the strengths and limitations of Mediterranean, plant-based, ketogenic, low-carbohydrate, carnivore and standard Western dietary patterns. The recurring message is that modern ultra-processed foods are fundamentally mismatched with human physiology which is why they contribute to chronic inflammation, insulin resistance, mitochondrial stress and metabolic dysfunction. Contrary to what most believe, food is not simply fuel. It interacts continuously with our metabolism, immune system, endocrine pathways, mitochondria and disease risk.

This paper explores something that sounds almost futuristic: detecting PCa from urine and breath samples alone. Using a combination of very accurate devices and an (I kid you not) electronic nose (eNose), the researchers analyzed volatile organic compounds (VOCs) released by patients with and without PCa. The concept is that cancer alters metabolism, producing unique chemical signatures that can be detected through breath and urine. In this study, the system identified dozens of distinct biomarkers and achieved accuracies approaching 88%, while the eNose system also reached remarkably high discrimination rates between cancer and control patients.

PSA testing has obvious value, but its lack of specificity continues to lead to unnecessary biopsies and patient anxiety. This type of analysis offers rapid, completely non-invasive screening that may eventually help identify cancer through metabolic fingerprints rather than anatomy alone. Obviously, this remains early-stage technology and larger validation studies are still needed. But future PCa detection may rely more on integrated biologic pattern recognition using AI and machine learning.

Bardoscia et al. highlight how PCa treatment is rapidly moving beyond the traditional “one-size-fits-all” approach centered largely around PSA and hormone suppression. The paper reviews a growing list of biomarkers capable of helping clinicians better understand the biologic behavior of metastatic castration-sensitive PCa and potentially select therapies more precisely. PCa is increasingly being understood as multiple biologically distinct diseases that may respond differently to treatment.

PCa management is gradually shifting from generalized treatment algorithms toward increasingly personalized biologic profiling. While much of this remains at the cutting edge, future PCa care will likely rely less on broad treatment categories and more on understanding the unique molecular fingerprint of an individual patient’s tumor.

Maryam et al. review omega-9 fatty acids, often associated with the Mediterranean diet, particularly oleic acid. Found abundantly in olive oil, avocados, nuts and seeds, omega-9 fats appear to exert anti-inflammatory and metabolic effects through inflammatory pathways, oxidative stress regulation, mitochondrial function and fat metabolism.

The cancer discussion becomes interesting because chronic inflammation, oxidative stress, insulin resistance and metabolic dysfunction all help create biologic environments favorable to growing cancers. Foods rich in omega-9 fatty acids appear to function best not as isolated “superfoods,” but as part of larger Mediterranean-style dietary patterns associated with lower inflammation and improved metabolic health.

The question addressed in this papers is what happens when poor diet and circadian disruption collide? Researchers evaluated DNA damage in day-shift versus night-shift workers while also examining dietary sugar intake. What was interesting was that fructose intake showed a significant positive correlation with DNA damage, but only in night-shift workers. In other words, the combination of circadian disruption (not sleeping at night) and high fructose consumption appeared to create a biologic environment associated with greater gene instability. The same relationship was not seen in daytime workers.

We know that cancer risk is rarely driven by a single factor in isolation. Sleep disruption, metabolic dysfunction, inflammation, dietary patterns and circadian biology appear to interact in complex ways. This paper suggests that fructose may become more biologically harmful when the body’s normal circadian repair systems are already disrupted. Timing, metabolism, and nutrition may all intersect way more than we once thought.